written by reader Immunomedics (IMMU)

by xiexgp | October 1, 2013 1:54 pm

Does anyone own Immunomedics, Inc. (IMMU)I’ve owned shares for several years now and it recently doubled in value. Not sure if I should hold or sell. Not much coverage on the stock, any info would be appreciated. Immunomedics is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Source URL: https://www.stockgumshoe.com/2013/10/microblog-immunomedics-immu/


3 responses to “written by reader Immunomedics (IMMU)”

  1. Jon E. says:

    This stock has run up and back down several times. The last time was because the product was based on mouse antibodies, and patients had bad reactions to the mouse protein, the company always needs money and dilutes your investment, and appearantly the CEO does not play well with others.

  2. DanTheMan says:

    A good recommendation if you are unsure about its future is to sell half of it. That way you’ve secured your initial investment and whatever happens thereafter is profit.

  3. R.Rogers says:

    Any information about Bill Gunderson top picks would be appreciated. Zach’s is another
    Site we wonder about …

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.